Radiolabeled Antibody Fragment for Preparation of (<sub>177</sub>Lu-DOTA)<sub>m</sub>-PAMAM G3.0-F(ab’)<sub>2</sub> trastuzumab as a Radiopharmaceutical for Cancer Therapy

Radiolabeled Antibody Fragment for Preparation of (<sub>177</sub>Lu-DOTA)<sub>m</sub>-PAMAM G3.0-F(ab’)<sub>2</sub> trastuzumab as a Radiopharmaceutical for Cancer Therapy

<p class="MsoNormal" style="margin-top: 0cm; margin-right: -3.4pt; margin-bottom: .0001pt; margin-left: -5.4pt; text-align: justify; mso-hyphenate: auto; tab-stops: 468.0pt;"><span style="font-size: 9.0pt;">Several radiolabeled monoclonal antibodies (mAbs) h...

Full description

Bibliographic Details
Main Authors: R.D. Haryuni, M. Ramli, T Triningsih, S Sutari
Format: Article
Language:English
Published: Center for Development of Nuclear Informatics, National Nuclear Energy Agency (BATAN) 2017-06-01
Series:Atom Indonesia
Subjects:
Radioimmunotherapy agent
Fragmentation
Trastuzumab
(177Lu)n-(DOTA)m-PAMAM G3.0-F(ab')2-trastuzumab
Online Access:http://aij.batan.go.id/index.php/aij/article/view/623

Similar Items

Similar Items